Join
Live feed
·
INSIDERFilingvia Quantisnow
Lucid Diagnostics Inc. logo

SEC Form 4: Pavmed Inc. acquired $4,369,447 worth of shares (2,230,144 units at $1.96) and acquired $2,105,012 worth of shares (1,145,086 units at $1.84), increasing direct ownership by 9% to 42,483,475 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LUCD (Lucid Diagnostics Inc.) and more on Quantisnow.